REIT - Mortgage
Compare Stocks
5 / 10Stock Comparison
SEVN vs WELL vs VTR vs TPVG vs OHI
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
Asset Management
REIT - Healthcare Facilities
SEVN vs WELL vs VTR vs TPVG vs OHI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Mortgage | REIT - Healthcare Facilities | REIT - Healthcare Facilities | Asset Management | REIT - Healthcare Facilities |
| Market Cap | $128M | $149.25B | $41.15B | $243M | $13.74B |
| Revenue (TTM) | $44M | $11.63B | $6.13B | $97M | $1.24B |
| Net Income (TTM) | $15M | $1.43B | $260M | $-12M | $632M |
| Gross Margin | 66.6% | 39.1% | -4.3% | 83.5% | 85.5% |
| Operating Margin | 75.3% | 4.4% | 13.4% | 77.9% | 64.3% |
| Forward P/E | 7.9x | 78.4x | 118.0x | 6.5x | 23.4x |
| Total Debt | $488M | $21.38B | $13.22B | $469M | $4.26B |
| Cash & Equiv. | $123M | $5.03B | $741M | $20M | $27M |
SEVN vs WELL vs VTR vs TPVG vs OHI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Seven Hills Realty … (SEVN) | 100 | 72.7 | -27.3% |
| Welltower Inc. (WELL) | 100 | 420.4 | +320.4% |
| Ventas, Inc. (VTR) | 100 | 247.6 | +147.6% |
| TriplePoint Venture… (TPVG) | 100 | 59.8 | -40.2% |
| Omega Healthcare In… (OHI) | 100 | 148.1 | +48.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SEVN vs WELL vs VTR vs TPVG vs OHI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SEVN ranks third and is worth considering specifically for growth.
- 96.4% FFO/revenue growth vs OHI's 14.0%
WELL is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 223.1% 10Y total return vs OHI's 110.0%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- Beta 0.13, yield 1.3%, current ratio 5.34x
- +42.7% vs SEVN's -18.1%
VTR is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.01, yield 2.1%
- Rev growth 18.5%, EPS growth 184.2%, 3Y rev CAGR 12.2%
- Beta 0.01 vs TPVG's 0.83, lower leverage
TPVG has the current edge in this matchup, primarily because of its strength in value and dividends.
- Lower P/E (6.5x vs 118.0x)
- 17.1% yield, vs WELL's 1.3%
OHI is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 1.00 vs TPVG's 6.41
- 51.0% margin vs VTR's 4.2%
- 6.1% ROA vs TPVG's -1.5%, ROIC 6.0% vs 7.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 96.4% FFO/revenue growth vs OHI's 14.0% | |
| Value | Lower P/E (6.5x vs 118.0x) | |
| Quality / Margins | 51.0% margin vs VTR's 4.2% | |
| Stability / Safety | Beta 0.01 vs TPVG's 0.83, lower leverage | |
| Dividends | 17.1% yield, vs WELL's 1.3% | |
| Momentum (1Y) | +42.7% vs SEVN's -18.1% | |
| Efficiency (ROA) | 6.1% ROA vs TPVG's -1.5%, ROIC 6.0% vs 7.2% |
SEVN vs WELL vs VTR vs TPVG vs OHI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
SEVN vs WELL vs VTR vs TPVG vs OHI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
OHI leads in 2 of 6 categories
WELL leads 1 • SEVN leads 0 • VTR leads 0 • TPVG leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
OHI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 265.9x SEVN's $44M. OHI is the more profitable business, keeping 51.0% of every revenue dollar as net income compared to VTR's 4.2%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $44M | $11.6B | $6.1B | $97M | $1.2B |
| EBITDAEarnings before interest/tax | $34M | $2.8B | $2.3B | -$22M | $1.1B |
| Net IncomeAfter-tax profit | $15M | $1.4B | $260M | -$12M | $632M |
| Free Cash FlowCash after capex | $16M | $2.5B | $1.4B | $35M | $912M |
| Gross MarginGross profit ÷ Revenue | +66.6% | +39.1% | -4.3% | +83.5% | +85.5% |
| Operating MarginEBIT ÷ Revenue | +75.3% | +4.4% | +13.4% | +77.9% | +64.3% |
| Net MarginNet income ÷ Revenue | +34.9% | +12.3% | +4.2% | +50.6% | +51.0% |
| FCF MarginFCF ÷ Revenue | +37.4% | +21.9% | +22.4% | -58.7% | +73.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.8% | +40.3% | +22.0% | — | +16.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -36.7% | +22.5% | 0.0% | -2.3% | +42.4% |
Valuation Metrics
Evenly matched — SEVN and TPVG each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 4.9x trailing earnings, TPVG trades at a 97% valuation discount to VTR's 160.3x P/E. Adjusting for growth (PEG ratio), OHI offers better value at 1.02x vs TPVG's 4.84x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $128M | $149.2B | $41.1B | $243M | $13.7B |
| Enterprise ValueMkt cap + debt − cash | $492M | $165.6B | $53.6B | $691M | $18.0B |
| Trailing P/EPrice ÷ TTM EPS | 8.42x | 153.25x | 160.26x | 4.91x | 23.78x |
| Forward P/EPrice ÷ next-FY EPS est. | 7.87x | 78.42x | 118.01x | 6.50x | 23.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 4.84x | 1.02x |
| EV / EBITDAEnterprise value multiple | 10.70x | 66.40x | 24.31x | 9.13x | 16.72x |
| Price / SalesMarket cap ÷ Revenue | 2.18x | 13.99x | 7.05x | 2.50x | 11.47x |
| Price / BookPrice ÷ Book value/share | 0.39x | 3.35x | 3.18x | 0.68x | 2.63x |
| Price / FCFMarket cap ÷ FCF | 8.53x | 52.41x | 31.25x | — | 15.64x |
Profitability & Efficiency
OHI leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
OHI delivers a 11.9% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-3 for TPVG. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to SEVN's 1.48x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs SEVN's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.1% | +3.5% | +2.1% | -3.4% | +11.9% |
| ROA (TTM)Return on assets | +2.0% | +2.3% | +1.0% | -1.5% | +6.1% |
| ROICReturn on invested capital | +5.1% | +0.5% | +2.5% | +7.2% | +6.0% |
| ROCEReturn on capital employed | +11.5% | +0.6% | +3.2% | +9.4% | +7.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 6 | 5 | 6 |
| Debt / EquityFinancial leverage | 1.48x | 0.49x | 1.05x | 1.33x | 0.78x |
| Net DebtTotal debt minus cash | $364M | $16.3B | $12.5B | $449M | $4.2B |
| Cash & Equiv.Liquid assets | $123M | $5.0B | $741M | $20M | $27M |
| Total DebtShort + long-term debt | $488M | $21.4B | $13.2B | $469M | $4.3B |
| Interest CoverageEBIT ÷ Interest expense | 1.52x | 0.26x | 1.40x | -1.02x | 3.83x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $8,649 for TPVG. Over the past 12 months, WELL leads with a +42.7% total return vs SEVN's -18.1%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs TPVG's -1.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +0.9% | +14.3% | +12.6% | -6.3% | +6.6% |
| 1-Year ReturnPast 12 months | -18.1% | +42.7% | +33.9% | +19.3% | +36.9% |
| 3-Year ReturnCumulative with dividends | +33.7% | +189.5% | +94.2% | -3.4% | +86.2% |
| 5-Year ReturnCumulative with dividends | +18.9% | +202.3% | +74.8% | -13.5% | +63.1% |
| 10-Year ReturnCumulative with dividends | +3.6% | +223.1% | +65.0% | +93.3% | +110.0% |
| CAGR (3Y)Annualised 3-year return | +10.2% | +42.5% | +24.8% | -1.2% | +23.0% |
Risk & Volatility
Evenly matched — VTR and OHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
OHI is the less volatile stock with a -0.13 beta — it tends to amplify market swings less than TPVG's 0.83 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs SEVN's 65.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.60x | 0.13x | 0.01x | 0.83x | -0.13x |
| 52-Week HighHighest price in past year | $12.86 | $219.59 | $88.50 | $7.53 | $49.14 |
| 52-Week LowLowest price in past year | $7.90 | $142.65 | $61.76 | $4.48 | $35.09 |
| % of 52W HighCurrent price vs 52-week peak | +65.5% | +97.0% | +97.8% | +79.5% | +93.9% |
| RSI (14)Momentum oscillator 0–100 | 56.2 | 60.2 | 56.2 | 58.3 | 48.6 |
| Avg Volume (50D)Average daily shares traded | 105K | 2.6M | 3.4M | 504K | 1.9M |
Analyst Outlook
Evenly matched — WELL and TPVG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SEVN as "Buy", WELL as "Buy", VTR as "Buy", TPVG as "Hold", OHI as "Hold". Consensus price targets imply 54.4% upside for SEVN (target: $13) vs 4.9% for VTR (target: $91). For income investors, TPVG offers the higher dividend yield at 17.11% vs WELL's 1.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $13.00 | $226.50 | $90.80 | $8.95 | $49.14 |
| # AnalystsCovering analysts | 4 | 34 | 32 | 12 | 28 |
| Dividend YieldAnnual dividend ÷ price | +14.7% | +1.3% | +2.1% | +17.1% | +5.4% |
| Dividend StreakConsecutive years of raises | 0 | 2 | 1 | 0 | 0 |
| Dividend / ShareAnnual DPS | $1.24 | $2.76 | $1.86 | $1.02 | $2.51 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.3% | 0.0% | 0.0% | 0.0% | 0.0% |
OHI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). WELL leads in 1 (Total Returns). 3 tied.
SEVN vs WELL vs VTR vs TPVG vs OHI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SEVN or WELL or VTR or TPVG or OHI a better buy right now?
For growth investors, Seven Hills Realty Trust (SEVN) is the stronger pick with 96.
4% revenue growth year-over-year, versus 14. 0% for Omega Healthcare Investors, Inc. (OHI). TriplePoint Venture Growth BDC Corp. (TPVG) offers the better valuation at 4. 9x trailing P/E (6. 5x forward), making it the more compelling value choice. Analysts rate Seven Hills Realty Trust (SEVN) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SEVN or WELL or VTR or TPVG or OHI?
On trailing P/E, TriplePoint Venture Growth BDC Corp.
(TPVG) is the cheapest at 4. 9x versus Ventas, Inc. at 160. 3x. On forward P/E, TriplePoint Venture Growth BDC Corp. is actually cheaper at 6. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Omega Healthcare Investors, Inc. wins at 1. 00x versus TriplePoint Venture Growth BDC Corp. 's 6. 41x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — SEVN or WELL or VTR or TPVG or OHI?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -13. 5% for TriplePoint Venture Growth BDC Corp. (TPVG). Over 10 years, the gap is even starker: WELL returned +223. 1% versus SEVN's +3. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SEVN or WELL or VTR or TPVG or OHI?
By beta (market sensitivity over 5 years), Omega Healthcare Investors, Inc.
(OHI) is the lower-risk stock at -0. 13β versus TriplePoint Venture Growth BDC Corp. 's 0. 83β — meaning TPVG is approximately -750% more volatile than OHI relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 148% for Seven Hills Realty Trust — giving it more financial flexibility in a downturn.
05Which is growing faster — SEVN or WELL or VTR or TPVG or OHI?
By revenue growth (latest reported year), Seven Hills Realty Trust (SEVN) is pulling ahead at 96.
4% versus 14. 0% for Omega Healthcare Investors, Inc. (OHI). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -16. 7% for Seven Hills Realty Trust. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SEVN or WELL or VTR or TPVG or OHI?
TriplePoint Venture Growth BDC Corp.
(TPVG) is the more profitable company, earning 50. 6% net margin versus 4. 3% for Ventas, Inc. — meaning it keeps 50. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TPVG leads at 77. 9% versus 3. 3% for WELL. At the gross margin level — before operating expenses — TPVG leads at 83. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SEVN or WELL or VTR or TPVG or OHI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Omega Healthcare Investors, Inc. (OHI) is the more undervalued stock at a PEG of 1. 00x versus TriplePoint Venture Growth BDC Corp. 's 6. 41x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, TriplePoint Venture Growth BDC Corp. (TPVG) trades at 6. 5x forward P/E versus 118. 0x for Ventas, Inc. — 111. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SEVN: 54. 4% to $13. 00.
08Which pays a better dividend — SEVN or WELL or VTR or TPVG or OHI?
All stocks in this comparison pay dividends.
TriplePoint Venture Growth BDC Corp. (TPVG) offers the highest yield at 17. 1%, versus 1. 3% for Welltower Inc. (WELL).
09Is SEVN or WELL or VTR or TPVG or OHI better for a retirement portfolio?
For long-horizon retirement investors, Omega Healthcare Investors, Inc.
(OHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 13), 5. 4% yield, +110. 0% 10Y return). Both have compounded well over 10 years (OHI: +110. 0%, TPVG: +93. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SEVN and WELL and VTR and TPVG and OHI?
These companies operate in different sectors (SEVN (Real Estate) and WELL (Real Estate) and VTR (Real Estate) and TPVG (Financial Services) and OHI (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SEVN is a small-cap high-growth stock; WELL is a mid-cap high-growth stock; VTR is a mid-cap high-growth stock; TPVG is a small-cap high-growth stock; OHI is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.